Targeting the Tumor Immune Microenvironment for Biomarker and Therapeutic Discovery in HCC

Dr. Valerie Chew from Duke-National University of Singapore (NUS) Medical School presents on biomarkers and therapies for Hepatocellular Carcinoma (HCC), the most common type of primary liver cancer.